SCHEMBL29336472

SCHEMBL29336472

CN(Cc1ccncc1)S(=O)(=O)c1c[nH]c2ccccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 1/20 0.45
▸ ALDH1A1 P00352 2/20 0.44
▸ HPGD P15428 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ HSD17B10 Q99714 2/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ IMPDH2 P12268 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ CDK4 P11802 2/20 0.41
▸ CCND1 P24385 1/20 0.41
▸ CDK2 P24941 1/20 0.41
▸ KDR P35968 1/20 0.40
▸ FNTA P49354 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5730432 0.77 MEN1 (0.47) ALDH1A1GAAHSD17B10MEN1KMT2A
SCHEMBL29336670 0.75 HTR6 (0.52) ALDH1A1HPGDLMNAGAAHSD17B10
SCHEMBL27249455 0.74 MEN1 (0.47) NAMPTALDH1A1HPGDLMNAMEN1
SCHEMBL11174358 0.74 NAMPT (0.62) NAMPTALDH1A1HPGDLMNAMEN1
Pyridine SCHEMBL27154153 0.69 SLC22A6 (0.46) ALDH1A1LMNAGAAHSD17B10IMPDH2
SCHEMBL30897273 0.69 ALDH1A1 (0.54) ALDH1A1HPGDLMNAGAAHSD17B10
SCHEMBL15416652 0.69 ALDH1A1 (0.54) ALDH1A1HPGDLMNAGAAHSD17B10
SCHEMBL29336734 0.69 CYP2D6 (0.48) ALDH1A1LMNAGAAKDM4ECYP2D6
SCHEMBL6667785 0.69 FNTA (0.64) MEN1KMT2AFNTAFNTB
SCHEMBL29557960 0.68 PBRM1 (0.52) ALDH1A1GAAMEN1KMT2AIMPDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF Université de Montréal (CA) 2024-07-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF NRAS, BRAF, KRAS NAMPT 702/4885ALDH1A1 1786/4885HPGD 824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback